Skip to main content

Month: September 2020

Alpine Income Property Trust, Inc. Announces Portfolio Acquisition of Three Single-Tenant Retail Properties Leased to Investment-Grade Rated Tenant Dollar General for Approximately $4.6 Million

DAYTONA BEACH, Fla., Sept. 21, 2020 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced the acquisition of a portfolio of three single-tenant net-leased retail income properties located in Maine and leased to an affiliate of Dollar General. The leases are guaranteed by the investment grade-rated Dollar General parent entity. The portfolio was purchased for approximately $4.6 million, representing a going-in cap rate of 6.85%. Each of the leases with Dollar General has approximately 13.1 years remaining on its initial lease term. The Company funded the acquisition with the Company’s line of credit. Dollar General is now the Company’s fifth largest tenant as a percentage of annualized base rent.Including this newly acquired portfolio, the Company’s total portfolio now consists of 43 properties...

Continue reading

Mid Penn Bancorp, Inc. announces retail consolidation plan

MILLERSBURG, Pa., Sept. 21, 2020 (GLOBE NEWSWIRE) — Mid Penn Bancorp, Inc. (“Mid Penn”) (NASDAQ: MBP), the parent company of Mid Penn Bank (the “Bank”) has announced the planned consolidation of three branches in the Bank’s retail network effective December 31, 2020. The consolidation, which affects its Malvern (Chester county), Pillow (Dauphin county), and Vanderbilt (Fayette county) locations, is part of Mid Penn’s strategy to optimize the delivery of banking services and in response to shifting consumer preferences.   Customers will continue to have access to nearby branches as well as a robust set of technology-based services.“As we prepare for new days ahead in our industry, we are continually evaluating how we deliver our brand of community banking to the customers and communities we serve. We are committed to providing easy...

Continue reading

ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020

TRYbeCA-1 Phase 3 trial in second-line metastatic pancreatic cancer:More than 90% of the planned 500 patients enrolledFast-Track designation granted by U.S. FDAInterim superiority analysis expected in Q1 2021; final analysis in 2H of 2021NOPHO-sponsored Phase 2 trial in second-line acute lymphoblastic leukemia:Completed patient enrollment: 55 patients enrolledEncouraging interim results: target level and duration of asparaginase activity reachedFinal data expected by the end of 2020Cash and cash equivalents of €45.4 million ($51.0 million) at the end of June 2020Cash horizon extended with a convertible bond financingEstablishment of At-The-Market (ATM) financing facility announcedLYON, France and CAMBRIDGE, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical...

Continue reading

Morphic Therapeutic to Present at the Jefferies Next Generation IBD Therapeutics Virtual Summit

WALTHAM, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) — Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced two presentations at the Jefferies Next Generation IBD Therapeutics Virtual Summit. Members of the Morphic management team are scheduled to participate in a panel discussion at 8:45 a.m. ET on Wednesday, September 23, 2020, as well as present a company overview at 1:00 p.m. ET on the same day.A live webcast of the company presentation will be available on the Investor section of Morphic’s website at https://www.morphictx.com. An archived replay will be available on the company’s website following the conference.About Morphic TherapeuticMorphic Therapeutic is a biopharmaceutical company developing...

Continue reading

ERYTECH fait le point sur ses activités et publie ses résultats semestriels 2020

Étude clinique de Phase 3 TRYbeCA-1 dans le traitement en seconde ligne du cancer du pancréas :Plus de 90% des patients recrutés sur un total prévu d’env. 500 patientsObtention de la désignation Fast Track de la FDA américaineAnalyse intermédiaire d’efficacité et analyse finale respectivement attendues au 1ertrimestre 2021 et au S2 2021Étude NOPHO de phase 2 IST dans le traitement en seconde ligne de la leucémie aiguë lymphoblastique :Finalisation du recrutement des patients avec 55 patients inscritsRésultats intermédiaires encourageants : niveau cible et durée de l’activité de l’asparaginase atteintsDonnées finales attendues d’ici la fin de l’année 2020Trésorerie et équivalents de trésorerie de 45,4 millions d’euros (51 millions de dollars) au 30 juin 2020Extension de l’horizon de trésorerie avec un financement par obligations...

Continue reading

Diamondback Energy, Inc. Releases 2020 Corporate Responsibility Report

MIDLAND, Texas, Sept. 21, 2020 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) today released its 2020 Corporate Responsibility Report. The online report outlines Diamondback’s commitment to environmental responsibility, managing and reducing risks, governance and business ethics, and our commitment to our people and communities. The report is available at www.diamondbackenergy.com/about/sustainability.“At Diamondback, we are committed to developing our natural resources in the Permian Basin safely and cognizant of our role in both our local and the global environment. We strive to meet progressively higher expectations for environmental sustainability, on-the-job safety, transparent governance and diversity and inclusion in our company. Our goal is to be a best-in-class oil and gas operator in terms of...

Continue reading

Synchronoss Technologies Appoints Jeff Miller Interim President and Chief Executive Officer

BRIDGEWATER, N.J., Sept. 21, 2020 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging, digital and IoT products, today announced that its Board of Directors has appointed Jeff Miller as interim President and Chief Executive Officer, effective immediately, in addition to his role as Chief Commercial Officer. He succeeds Glenn Lurie who has resigned as the Company’s President and Chief Executive Officer, and as a member of its Board of Directors, following the Board of Directors’ review of allegations of personal misconduct by Mr. Lurie in violation of the Company’s policies. His resignation is not related to the Company’s strategy, financial or business performance. Given the expectation that all employees will respect Synchronoss’ values and adhere to the Company’s...

Continue reading

Hallmark Financial Announces Resignation of Chief Financial Officer

DALLAS, Sept. 21, 2020 (GLOBE NEWSWIRE) — Hallmark Financial Services, Inc. (“Hallmark Financial” or “Company”) (NASDAQ: HALL), a specialty property and casualty insurance company, today announced that on September 15, 2020, Jeff Passmore, Chief Financial Officer, submitted his resignation. Mr. Passmore will remain with the Company through October 9, 2020, to facilitate an orderly transition.Naveen Anand, President & Chief Executive Officer, stated “On behalf of Hallmark, we want to thank Jeff for his contributions to the organization over the past 18 years, and we wish him well as he pursues a new opportunity.”The Company has commenced a search for a new CFO. “We are taking this opportunity to conduct a formal search for a new CFO and to continue to expand the depth of our executive bench strength,” explains Mr. Anand.In the...

Continue reading

BioLife Sciences (BLFE) Announces Distribution Agreement With BeMotion Inc.

Toronto, Sept. 21, 2020 (GLOBE NEWSWIRE) — via NewMediaWire —BioLife Sciences Inc. (OTC Markets: BLFE) announced today that it has entered into an agreement with BeMotion Inc. to become a licensed distributor of the company’s innovative technology products.Under the terms of the agreement, BioLife Sciences will gain the right to distribute products by BeMotion which include non-contact human temperature screening technology, ultraviolet sterilization, and touchless vending/marketplaces, currently used by police departments, airports and educational institutions. BeMotion Inc. CEO Mr. Hussein Abu Hassan commented: “We saw a partnership with BioLife Sciences as an excellent opportunity to expand our North American network of sales and distribution.”According to Markets and Markets the global temperature sensor market size is...

Continue reading

Frederick 911 Communications Center Promotes the Success of SteraMist After Purchase of Surface Unit

BEVERLY HILLS, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZD), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products – a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). TOMI is proud to announce that its local Operations Headquarters Frederick 911 Communications Center purchased a SteraMist Surface Unit to be used throughout its office to combat COVID-19, quickly promoting it within days through an article in The Frederick News-Post: Top-of-the-line disinfecting device delivered to county 911 call center.TOMI’s innovative SteraMist technology has become a trusted partner with growing number of first responder and front-line agencies...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.